ArticleJournal of Alzheimer's disease : JAD2013

AβPP-selective BACE inhibitors (ASBI): novel class of therapeutic agents for alzheimer's disease.

Olivier Descamps et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.